Autumn Glory Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.92M Buy
2,521
+93
+4% +$110K 0.81% 34
2026
Q2
$2.91M Buy
+2,428
New +$2.48M 0.83% 31
2026
Q1
– Sell
-1,367
Closed -$1.47M – 218
2025
Q4
$1.47M Sell
1,367
-311
-19% -$297K 0.51% 54
2025
Q3
$1.28M Buy
1,678
+634
+61% +$472K 0.53% 53
2025
Q2
$814K Buy
1,044
+341
+49% +$265K 0.38% 71
2025
Q1
$2.58M Buy
703
+12
+2% +$10K 1.28% 19
2024
Q4
$533K Buy
+691
New +$572K 0.26% 94

Other funds holding LLY

Autumn Glory Partners's LLY Position: Q3 2026 in Review

Autumn Glory Partners increased its Eli Lilly (LLY) stake by 3.8% in Q3 2026, buying an estimated $110K and bringing the position to 2,521 shares worth $2.92M. The position accounts for 0.81% of the portfolio, ranked #34.

Autumn Glory Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Autumn Glory Partners held 2,521 shares of Eli Lilly worth $2.92M as of Q3 2026.
  • Autumn Glory Partners bought 93 Eli Lilly shares in Q3 2026, an estimated $110K.
  • Eli Lilly made up 0.81% of Autumn Glory Partners's portfolio in Q3 2026, its #34 holding.
  • Autumn Glory Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Autumn Glory Partners's 13F filing for Q3 2026, filed 26 Oct 2026.